Why the study?
The diaphragm plays an under-recognized role in cardiac function, and targeting diaphragmatic changes in heart failure may provide a novel treatment pathway.
Do therapies targeting the diaphragm (inspiratory muscle training or device-based stimulation) improve outcomes in patients with heart failure?
Do therapies targeting the diaphragm (inspiratory muscle training or device-based stimulation) improve outcomes in patients with heart failure?
Targeting diaphragmatic dysfunction through inspiratory muscle training or device-based stimulation represents a potential novel therapeutic pathway for patients with heart failure.
In addition to the diaphragm’s role as the primary respiratory muscle, it also plays an under-recognized role in cardiac function. It serves as a pump facilitating venous and lymph return, modulating left ventricular afterload hemodynamics and pericardial pressures, as well as regulating autonomic tone. Heart failure (HF) is associated with diaphragmatic changes (ie, muscle fiber atrophy and weakness, increased ratio of type I to type II muscle fibers, and altered muscle metaboreflex) that lead to diaphragmatic dysfunction with subsequent symptomatic manifestations of HF. Herein, it is proposed that targeting the diaphragm in patients with HF via inspiratory muscle training or device-based stimulation can provide a novel treatment pathway for HF. Reviewed are several potential mechanisms through which therapies targeting the diaphragm can be beneficial in HF (ie, improving preload reserve, atrial and ventricular synchrony, and metaboreflex activity; reducing pericardial restraint; and restoring diaphragm strength).
No takes yet. Share an insight, caveat, or question.
Salah et al. (2022) conducted a review in Heart failure. Targeting the diaphragm (inspiratory muscle training or device-based stimulation) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: